Clinical Trial Update: Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide given during and after radiotherapy in patients with newly diagnosed glioblastoma multiforme who had previous surgery an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: TERMINATED